Post-approval studies (Phase 4)UnknownNCT01581749What this trial is testingEvaluation of Truebeam for Low-Intermediate Risk Prostate CancerWho this might be right forProstate Neoplasms Albert DeNittis 50
Not applicableUnknownNCT03225235What this trial is testingProspective Evaluation of Hypofractionated Stereotactic RT Using CyberKnife for Patients With Prostate CancerWho this might be right forProstate Cancer The Greater Poland Cancer Centre 600
Not applicableStudy completedNCT01368055What this trial is testingHypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate CancerWho this might be right forProstate Cancer University of Florida 361
Testing effectiveness (Phase 2)WithdrawnNCT01409473What this trial is testingStereotactic Body Radiotherapy (SBRT) With Concurrent Boost for Low- and Intermediate-Risk Prostate CancerWho this might be right forProstate Cancer Rocky Mountain Cancer Centers
Not applicableActive Not RecruitingNCT05668351What this trial is testingStereotactic Ablative Radiation Therapy for Prostate CancerWho this might be right forProstate Cancer Medical University of South Carolina 42
Not applicableLooking for participantsNCT06200974What this trial is testingMulti-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate CancerWho this might be right forLocalized Prostate Carcinoma British Columbia Cancer Agency 100
Not applicableActive Not RecruitingNCT02623933What this trial is testingMRI Assisted Focal Boost With HDR Monotherapy for Prostate Cancer PatientsWho this might be right forProstate Cancer Sunnybrook Health Sciences Centre 60
Not applicableUnknownNCT05073653What this trial is testing68Ga-GRP PET/CT for Imaging in Low and Intermediate Risk Prostate CancerWho this might be right forProstate Cancer Xiangya Hospital of Central South University 80
Not applicableUnknownNCT03979573What this trial is testingProspective Evaluation of Mp-MRI, MR-guided Biopsy, and Molecular Markers for Active Surveillance of Prostate CancerWho this might be right forProstate Cancer Heinrich-Heine University, Duesseldorf 90
Testing effectiveness (Phase 2)Study completedNCT01146340What this trial is testingSafety and Efficacy Study of Dose-escalated Hypofractionated Radiotherapy For Prostate CancerWho this might be right forProstate Cancer Sunnybrook Health Sciences Centre 30
Not applicableEnded earlyNCT05826470What this trial is testingInvestigator Initiated Trial to Further Evaluate the Safety and Efficacy of Trans-perineal Focal Laser Ablation of Localized Prostate Cancer Using High Frequency Micro-ultrasound ImagingWho this might be right forProstate CancerLow-risk or Favorable Intermediate Risk Prostate Cancer Who Are on an Active Surveillance Regimen Genesis Research LLC 4
Not applicableEnded earlyNCT01414712What this trial is testingCirculating Tumor Cells in Prostate Cancer PatientsWho this might be right forProstate Cancer University of Texas Southwestern Medical Center 2
Not applicableStudy completedNCT01780701What this trial is testingMagnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate CancerWho this might be right forProstate Cancer OHSU Knight Cancer Institute 66
Not applicableLooking for participantsNCT07112781What this trial is testingFeasibility Trial of Single-Dose Radiotherapy for Localized Low and Intermediate Risk Prostate CancerWho this might be right forProstate Cancer Branch Office of "Hadassah Medical Ltd" 30
Not applicableStudy completedNCT00693238What this trial is testingProton Therapy for Low and Intermediate Risk Prostate CancerWho this might be right forProstate Cancer University of Florida 228
Testing effectiveness (Phase 2)Looking for participantsNCT06347705What this trial is testing2141-V11 in Combination With Standard Treatments in People With Prostate CancerWho this might be right forProstate Cancer Memorial Sloan Kettering Cancer Center 57
Not applicableNot Yet RecruitingNCT07210502What this trial is testingSide Effects of Low Dose Rate Brachytherapy and Ultra-hypofractionated Radiotherapy in Low to Intermediate Risk Prostate CancerWho this might be right forProstate Adenocarcinoma Royal Surrey County Hospital NHS Foundation Trust 220
Not applicableStudy completedNCT03424694What this trial is testingHDR Brachytherapy as Monotherapy for Low and Intermediate Risk Prostate CancerWho this might be right forProstate Cancer CR-CSSS Champlain-Charles-Le Moyne 199
Not applicableUnknownNCT02070952What this trial is testingCyberKnife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate CancerWho this might be right forProstate Cancer Riverside Community Hospital, California 167
Not applicableStudy completedNCT00643617What this trial is testingCyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy DosimetryWho this might be right forProstate CancerProstatic CancerProstatic Neoplasms+2 more Accuray Incorporated 307